Trilogy Capital’s Vanguard Short-Term Corporate Bond ETF VCSH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$339K Buy
4,382
+140
+3% +$11K 0.01% 318
2026
Q2
$335K Sell
4,242
-500
-11% -$39.5K 0.01% 317
2026
Q1
$376K Buy
4,742
+917
+24% +$73.1K 0.02% 293
2025
Q4
$305K Buy
3,825
+400
+12% +$31.9K 0.01% 311
2025
Q3
$274K Buy
3,425
+175
+5% +$13.9K 0.01% 328
2025
Q2
$258K Sell
3,250
-181
-5% -$14.3K 0.01% 319
2025
Q1
$271K Buy
+3,431
New +$269K 0.01% 297
2023
Q2
– Sell
-29,011
Closed -$2.21M – 272
2023
Q1
$2.21M Buy
+29,011
New +$2.2M 0.16% 90

Other funds holding VCSH

Trilogy Capital's VCSH Position: Q3 2026 in Review

Trilogy Capital increased its Vanguard Short-Term Corporate Bond ETF (VCSH) stake by 3.3% in Q3 2026, buying an estimated $11K and bringing the position to 4,382 shares worth $339K. The position accounts for 0.01% of the portfolio, ranked #318.

Trilogy Capital first reported a position in VCSH in Q1 2023 and has held it in 8 quarters since. The position peaked at $2.21M in Q1 2023. 946 funds tracked by Wall St. Rank hold VCSH as of Q3 2026.

  • Trilogy Capital held 4,382 shares of Vanguard Short-Term Corporate Bond ETF worth $339K as of Q3 2026.
  • Trilogy Capital bought 140 Vanguard Short-Term Corporate Bond ETF shares in Q3 2026, an estimated $11K.
  • Vanguard Short-Term Corporate Bond ETF made up 0.01% of Trilogy Capital's portfolio in Q3 2026, its #318 holding.
  • Trilogy Capital first reported a position in Vanguard Short-Term Corporate Bond ETF in Q1 2023 and has held it in 8 quarters since.
  • Trilogy Capital's Vanguard Short-Term Corporate Bond ETF position peaked at $2.21M in Q1 2023.
  • 946 funds tracked by Wall St. Rank held Vanguard Short-Term Corporate Bond ETF as of Q3 2026.

Based on Trilogy Capital's 13F filing for Q3 2026, filed 20 Oct 2026.